IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q2 2018 Holdings

Filed 2018-08-02 | 53 holdings | $2.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$580.0K2,00026.4%
Axogen Inc(AXGN)COM05463X106$603.0K12,00027.4%
Corcept Therapeutics Inc(CORT)COM218352102$786.0K50,00035.8%
PreviousPage 2 of 2